CREATINE MAGNA POWER Mega Caps
CREATINE MAGNA POWER® Dietary food in capsules containing magnesium creatine chelate.
A preparation enriching the diet with creatine and magnesium, in the form of a patented magnesium creatine chelate CREATINE MAGNA POWER®
Consumption of creatine contributes to the increase of physical capacity during short, repetitive high-intensity exercises (from a dosage of 3 g per day).
Creatine is the most effective – alongside arginine – anabolic agent on the market. This fact has been confirmed by both numerous scientific studies and years of use in sport. However, full utilisation of creatine as a supplement stimulating the growth of strength and mass is limited by lactamation where the majority of ingested creatine is converted into inactive creatinine. During this reaction, the amine group of creatine is bound with its acid group which results in the closing of the molecule, production of creatinine and the loss of anabolic activity. This reaction is accelerated by the high acidity of the ready-to-consume creatine solutions, as well as of the upper section of the digestive system.
Ingredients: 85,3% CREATINE MAGNA POWER® magnesium creatine chelate, bulking agent – microcrystalline cellulose; anti-caking agent – magnesium salts of fatty acids; capsule (gelatine, colour: E 171).
|Nutrition declaration||2 capsules||4 capsules||6 capsules||per 100 g|
|Energy||8 kcal/ 34 kJ||16 kcal/ 69 kJ||24 kcal/ 103 kJ||315 kcal/ 1325 kJ|
of which saturates
|< 0,5 g
< 0,1 g
|< 0,5 g
< 0,1 g
|< 0,5 g
of which sugars
|Protein||0 g||0 g||0 g||0 g|
|Salt||< 0,01 g||0,01 g||0,02 g||0,25 g|
|CREATINE MAGNA POWER™ magnesium creatine chelate, incl.:||2200 mg||4400 mg||6600 mg||85,3 g|
|Magnesium||176 mg (47%*)||352 mg (94%*)||528 mg (141%*)||6,8 g (1813%*)|
*NRVs - nutrient reference values
Recommended use: take 2 capsules two times a day – before breakfast and after training, drinking with large amount of water. An increase of weight may happen. Not suitable for children and young people. Keep out of reach of children.
Feldman E. "Creatine: A Dietary Supplement and Ergogenic Aid", Nutritional Reviews, Vol 57 No. 2:45-50, 1999.
Clark JF, "Creatine: A Review of Its Nutritional Applications in Sports", Nutrition, Vol 14, No. 3, 322-324, 1998.
Harris Rd, Soderlund K. Hultman E, "Elevation of Creatine in Resting and Exercising Muscle of Normal Subjects by Creatine Supplementation", Clin Sci 1992, 83:367.
Green Al, Hultman E. MacDonald IA, Sewell DA, Greenhaff RI., "Carbohydrate Ingestion Augments Skeletal Muscle Creatine Accumulation During Creatine Supplementation in Man", Am J Physiol 1996: 271:E821.
Vandengerg K. Gellis N, Vanleemputte M, et al, "Caffeine Counteracts the Ergogenic Action of Muscle Creatine Loading", J Appl Phys 1996; 80:452-457.
S. Ferraro et al; Clin. Cardiol. 19, 9, 699-703 (1996)
M. Cafiero et al; Clin Ter. 144, 4, 34-8 (1994).
D.J. Chambers et al; Ann. Thorac. Surg. 6, 1, 67-75 (1996).
P. guichard, J.E. Burkhardt and N.W. Seidler; Med. Hypotheses 45, 1, 41-44 (1995).
M. Daniel Becque, John D. Lochmann, and Donald R. Melrose "Effects of oral creatine supplementation on muscular strength and body composition", Med & Sci in Sports & Exercise, 32, No.3, 654-658 (March 2000).
Magnesium Creatine Chelate Newest Concept in Ergogenics Max R. Motyka, M.S., R.Ph. Albion Laboratories, Inc.
Synergestic Effects of Magnesium and Creatine on Ergogenic Performance in Rats H. Dewayne Ashmead, PhD* Alain Bourdonnais, DVM† Stephen D. Ashmead, MS* Albion Advanced Nutrition*Clearfield, Utah †St. Brieuc, France
Magnesium-Creatine Supplementation Effects on Body Water L.R. Brilla, M.S. Giroux, A. Taylor, and K.M. Knutzen (2003)
Magnesium-creatine supplementation effects on exhaustive exercise.
Study by: Dr. L.R. Brilla, J.S. Kennedy, K.M. Knutzen Western Washington University, Bellingham, WA Am J Clin Nutr, V75, 2(S) Feb 2002
Magnesium-creatine supplementation effects on anaerobic power and fatigue in humans Study by: L.R. Brilla, M. Giroux, A. Taylor, K. Knutzen Western Washington University, WA Experimental Biology 2002, FASEB Journal, March 22, 2002 Vol. 16, No. 5.